Precision Optics Announces Appointment of Jonathan Everett as VP of Engineering

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

GARDNER, Mass., Feb. 3, 2020 /PRNewswire/ — Precision Optics Corporation, Inc. (OTCQB: PEYE), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced the appointment of Jonathan Everett as the Company’s new Vice President of Engineering.

Mr. Everett joins Precision Optics from BAE Systems from their Precision Guidance and Sensing Solutions business where he was focused on new product development for next generation multispectral targeting systems, with expertise in optics and electro optics for both development stage programs, as well as current production products. Overall, Mr. Everett’s career spans over 25 years of technical leadership experience, individual contribution to new product development, and program management with companies manufacturing electro-optical products for military, medical, industrial, and commercial markets. Prior to BAE Systems, he was Director of Program Management and Chief Engineer for Technology Development at American Science and Engineering from 2014 to 2018. Previous positions include Director of Programs and Engineering at General Dynamics Global Imaging Technologies, Engineering Manager – Defense Systems & Electro-Optics at Elbit Systems of America (fmr. Kollsman), Product Manager – Optical Metrology at Optikos Corporation, and as Optical Product Manager at Diversified Optical Products. Mr. Everett holds a BS from University of Rochester in Optics, is named on numerous patents and has published a number of articles.

Precision Optics’ CEO, Joseph Forkey, commented, “I am pleased to announce the appointment of Jon Everett to the newly created position of VP of Engineering. Jon has tremendous experience in developing new optical-based technologies and products for a number of the world’s industry leaders. His extensive experience in the defense industry aligns well with our efforts to expand our presence in that market.  Overall, the expansion of our engineering capabilities is a key growth objective for the Company as we look to further expand our efforts to develop new technologies, increase our product development pipeline and move existing development projects towards commercialization. I look forward to leveraging Jon’s experience and leadership as we continue to grow our business going forward.”

Jon Everett commented, “I have been impressed with Precision Optics technology and with the capabilities of their technical team.  I am happy to be joining the company at such an exciting time and look forward to contributing to the ongoing development of optical technology, particularly in micro-optics and 3D systems, as well as the transfer of this technology into products for customers.”

About Precision Optics Corporation
Precision Optics Corporation enables innovation in minimally invasive surgery, diagnostics and treatment through optics and photonics. Precision Optics Corporation has been a leading developer and manufacturer of advanced optical instruments since 1982. Using proprietary optical technologies, the Company designs and produces next generation medical instruments, MicroprecisionTM micro-optics with characteristic dimensions less than 1 millimeter, and other advanced optical systems for market-leading medical device companies. The Company’s innovative medical instrumentation line includes state-of-the-art endoscopes and endocouplers as well as custom illumination and imaging products for use in minimally invasive surgical procedures. The Company believes that current advances in its proprietary micro-optics and 3D imaging technologies present significant opportunities for expanding applications to numerous potential medical products and procedures. The Company’s website is www.poci.com. Investors can find Real-Time Quotes and market information for the Company on www.otcmarkets.com/stock/PEYE/quote.

About Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements include, but are not limited to, statements that express the Company’s intentions, beliefs, expectations, strategies, predictions or any other statements related to the Company’s future activities or future events or conditions. These statements are based on current expectations, estimates and projections about the Company’s business based, in part, on assumptions made by the Company’s management. These statements are not guarantees of future performances and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors, including those risks discussed in the Company’s annual report on Form 10-K and in other documents that we file from time to time with the SEC. Any forward-looking statements speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement, except as required by law. 

Company Contact:
PRECISION OPTICS CORPORATION
22 East Broadway
Gardner, Massachusetts 01440-3338
Telephone: 978-630-1800

Investor Contact:
LYTHAM PARTNERS, LLC
Robert Blum
Phoenix | New York
Telephone: 602-889-9700
peye@lythampartners.com

View original content:http://www.prnewswire.com/news-releases/precision-optics-announces-appointment-of-jonathan-everett-as-vp-of-engineering-300997816.html

SOURCE Precision Optics Corporation

Staff

Recent Posts

NJ Rallies Investment Power, Leveraging Capital from Garden State Venture Partners to Drive MedTech and Maternal Health Innovation

GLASSBORO, N.J.--(BUSINESS WIRE)--Two transformative healthcare announcements this week mark a new era for New Jersey’s…

3 minutes ago

Revival Healthcare Capital Announces Strategic Partnership to Accelerate External Innovation in Robotics With up to $458 Million Joint Investment With Olympus Into Co-Founded New Company Swan EndoSurgical

AUSTIN, Texas--(BUSINESS WIRE)--Revival Healthcare Capital (Revival), an investment firm focused on transformative external innovation partnerships…

4 minutes ago

Establishment Labs to Announce Second Quarter 2025 Financial Results on August 7

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to…

3 hours ago

HCA Healthcare Reports Second Quarter 2025 Results

Raises 2025 GuidanceNASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results…

3 hours ago

Numinus Wellness Inc. Announces Fourth Quarter Fiscal 2024 Results

Q4 Fiscal 2024 Highlights1Revenue of $1.2 million, a 16.4% increase over Q3 2024Gross profit of…

3 hours ago

Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $2.5 Million Gross Proceeds

King of Prussia, Pennsylvania--(Newsfile Corp. - July 25, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO),…

6 hours ago